Replies to post #10302 on Momenta Pharmaceuticals, Inc. (MNTA)

[jmkobers]

<<And with a burn rate over 100 million annually and no other revenue generating product less than 5-8 years out, they should be>>

In thinking about this more, not sure it is valid. MNTA has never shown great regard for shareholder value, so I doubt they care that much if approval comes and competitors are able to repeat mEnox scenario. Obviously they would prefer it not happen, but in this case they will just dilute as they see fit. They will still make their money on options regardless. MNTA shareholders on the other hand.......